Surprising benefits beyond the scales
Beyond weight, patients sometimes notice changes in cravings, portion control or cardiometabolic markers—within expectations for the drug class.
Improved post-meal glucose excursions, lower blood pressure in some individuals and reduced inflammatory markers can accompany weight change—always tracked clinically rather than assumed.
Behavioural “wins” such as less night-time eating or better tolerance for walking may improve quality of life early.
Not every effect is positive for everyone; mood changes or food aversion warrant discussion.
Celebrate non-scale victories but stay engaged with objective monitoring arranged by your care team.
This content is for general education only and does not replace an individual medical consultation.